Asensus Surgical Inc (ASXC) USD0.001

- Add to watchlist
- This stock can be held in a




Business summary
Asensus Surgical, Inc. is a medical device company that is digitizing the interface between the surgeon and the patient through Performance-Guided Surgery. The Company is focused on the market development and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital and multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits, such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation, including three-millimeter (mm) micro laparoscopic instruments, five mm articulating instruments, eye-sensing camera control and fully reusable standard instruments to patients around the world. Its Senhance System is used in Europe for adult and pediatric laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.
Contact details
Important dates
General stock information
- Short code:
- ASXC
- ISIN:
- US04367G1031
- Market cap:
- $90.33 million
- Shares in issue:
- 236.46 million
- Sector:
- Health Care Equipment
- Exchange:
- -
- Country:
- United States
- Currency:
- US dollar
- Indices:
- n/a
Key personnel

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.